Correction to: Safety Profile and Therapeutic Efficacy of One Cycle of Lu177-PSMA in End-Stage Metastatic Castration-Resistant Prostate Cancer Patients with Low Performance Status

Nucl Med Mol Imaging. 2020 Oct;54(5):268. doi: 10.1007/s13139-020-00663-6. Epub 2020 Aug 15.

Authors

Manoj Gupta¹, Partha Sarathi Choudhury¹, Sudhir Rawal², G Karthikeyan³, Vineet Talwar⁴, Kumar Deep Dutta⁴, Amitabh Singh²

Affiliations

¹ Department of Nuclear Medicine, Rajiv Gandhi Cancer Institute and Research Centre, Delhi, India.
² Department of Uro - Gynae Surgical Oncology, Rajiv Gandhi Cancer Institute and Research Centre, Delhi, India.
³ Amity Institute of Virology and Immunology, Amity University, Noida, Uttar Pradesh India.
⁴ Department of Medical Oncology, Rajiv Gandhi Cancer Institute and Research Centre, Delhi, India.

Abstract

[This corrects the article DOI: 10.1007/s13139-019-00624-8.].

© Korean Society of Nuclear Medicine 2020.

Publication types

Published Erratum